Blood Cells Molecules and Diseases

(The TQCC of Blood Cells Molecules and Diseases is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
Increased expression of CD8 marker on T-cells in COVID-19 patients110
Leukocyte adhesion to P-selectin and the inhibitory role of Crizanlizumab in sickle cell disease: A standardized microfluidic assessment35
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies30
ABO blood groups, COVID-19 infection and mortality26
Direct and indirect effects of the SARS-CoV-2 pandemic on Gaucher Disease patients in Spain: Time to reconsider home-based therapies?25
Effectiveness of convalescent plasma in Indian patients with COVID-1924
Hematologically important mutations: The autosomal forms of chronic granulomatous disease (third update)23
Hematologically important mutations: X-linked chronic granulomatous disease (fourth update)20
Down-regulation of lncRNA NEAT1 regulated by miR-194-5p/DNMT3A facilitates acute myeloid leukemia20
Circ-PTK2 promotes the proliferation and suppressed the apoptosis of acute myeloid leukemia cells through targeting miR-330-5p/FOXM1 axis18
Facing COVID-19 in the hematopoietic cell transplant setting: A new challenge for transplantation physicians16
Is the erythropoietin-erythroferrone-hepcidin axis intact in human neonates?16
A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis15
MicroRNA expression patterns in HbE/β-thalassemia patients: The passwords to unlock fetal hemoglobin expression in β-hemoglobinopathies14
BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival14
Potential causal role of l-glutamine in sickle cell disease painful crises: A Mendelian randomization analysis14
Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database13
Upregulation of cytokine signalling in platelets increases risk of thrombophilia in severe COVID-19 patients12
EPAS1 regulates proliferation of erythroblasts in chronic mountain sickness12
The potential role of emicizumab prophylaxis in severe von Willebrand disease12
Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study12
Lysophosphatidic acid-induced pro-thrombotic phosphatidylserine exposure and ionophore-induced microvesiculation is mediated by the scramblase TMEM16F in erythrocytes11
Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions11
Hematologically important mutations: Leukocyte adhesion deficiency (second update)10
Hypoxia induced up-regulation of tissue factor is mediated through extracellular RNA activated Toll-like receptor 3-activated protein 1 signalling10
Benserazide as a potential novel fetal hemoglobin inducer: an observational study in non-carriers of hemoglobin disorders9
Mitapivat increases ATP and decreases oxidative stress and erythrocyte mitochondria retention in a SCD mouse model9
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria9
The IL-33 Receptor/ST2 acts as a positive regulator of functional mouse bone marrow hematopoietic stem and progenitor cells9
Clinical and health-related quality of life outcomes of transfusion-dependent thalassaemia patients in Singapore9
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of India9
Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia9
Severe immune thrombocytopenia after COVID-19 vaccination: Report of four cases and review of the literature9
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction9
Potential ‘significance’ of monoclonal gammopathy of ‘undetermined significance’ during COVID-19 pandemic8
RNF220 promotes the proliferation of leukaemic cells and reduces the degradation of the Cyclin D1 protein through USP228
Effects of Eupalinilide E and UM171, alone and in combination on cytokine stimulated ex-vivo expansion of human cord blood hematopoietic stem cells8
Prognostic factors associated with COVID-19 related severity in sickle cell disease8
Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease8
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia7
The association of HBG2, BCL11A, and HBS1L-MYB polymorphisms to thalidomide response in Chinese β-thalassemia patients7
Biomarkers and genetic modulators of cerebral vasculopathy in sub-Saharan ancestry children with sickle cell anemia7
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort7
Loss of ZNF215 imprinting is associated with poor five-year survival in patients with cytogenetically abnormal-acute myeloid leukemia7
Early iron supplementation and iron sufficiency at one month of age in NICU patients at-risk for iron deficiency7
Novel mutations in the bone morphogenetic protein 6 gene in patients with iron overload and non-homozygous genotype for the HFE p.Cys282Tyr mutation7
High-throughput methods for the analysis of transcription factors and chromatin modifications: Low input, single cell and spatial genomic technologies7
Targeted gene expression study using TaqMan low density array to gain insights into venous thrombo-embolism (VTE) pathogenesis at high altitude6
Novel mutations in the EPO-R, VHL and EPAS1 genes in the Congenital Erythrocytosis patients6
Aberrant expression of cytokines in polycythemia vera correlate with the risk of thrombosis6
A case series highlighting structured hematological, biochemical and molecular approach to clinical oral iron refractoriness in children: A pressing need for a 3-tier system for classification of vari6
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort6
VCAM1, HMOX1 and NOS3 differential endothelial expression may impact sickle cell anemia vasculopathy5
Pediatric bone marrow failure: Clinical, hematological and targeted next generation sequencing data5
Bone marrow burden score is not useful as a follow-up parameter in stable patients with type 1 Gaucher disease after 5 years of treatment5
No evidence that chloroquine or hydroxychloroquine induce hemolysis in G6PD deficiency5
The significance of surface neutrophilic MPO expression level in NETosis and NETosis-associated coagulopathies in covid-19 infected patients5
Splicing analysis of SLC40A1 missense variations and contribution to hemochromatosis type 4 phenotypes5
Prognostic significance of CD45 antigen expression in pediatric acute lymphoblastic leukemia5
Development of a Thalassemia International Prognostic Scoring System (TIPSS)5
A computational study of structural differences of binding of NADP+ and G6P substrates to G6PD Mediterraneanc.563T, G6PD A−c.202A/c.376G, G6PD Cairoc.404C and G6PD Gazac.536A mutations5
γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity5
Effects of d-ribose on human erythrocytes: Non-enzymatic glycation of hemoglobin, eryptosis, oxidative stress and energy metabolism4
Sirolimus for treatment of refractory primary warm autoimmune hemolytic anemia in children4
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment4
Comparison of CRP and procalcitonin for etiological diagnosis of fever during febrile neutropenia in hematology patients- an experience from a tertiary care center in Northern India4
Mutations in RASGRP2 gene identified in patients misdiagnosed as Glanzmann thrombasthenia patients4
A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients4
Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR)4
Good treatment-free survival of monoclonal gammopathy of undetermined significance associated pure red cell aplasia after bortezomib plus dexamethasone4
Novel histone deacetylase inhibitor CT-101 induces γ-globin gene expression in sickle erythroid progenitors with targeted epigenetic effects4
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study4
Differential tissue specific expression of Kif23 alternative transcripts in mice with the human mutation causing congenital dyserythropoietic anemia type III4
Age-dependent characterization of carotid and cerebral artery geometries in a transgenic mouse model of sickle cell anemia using ultrasound and microcomputed tomography4
Identification and characterization of novel mutations in Chinese patients with congenital fibrinogen disorders4
TMEM16F mediated phosphatidylserine exposure and microparticle release on erythrocyte contribute to hypercoagulable state in hyperuricemia4
The effect of transfusion on immune responses in thalassemia4
Haemoglobin Bristol-Alesha in a child with non-spherocytic severe haemolytic anaemia and marked anisochromic poikilocytosis with basophilic stippling and amorphous intracellular content4
ANKHD1 is an S phase protein required for histone synthesis and DNA repair in multiple myeloma cells4
Modulation of red blood cell oxygen affinity with a novel allosteric modifier of hemoglobin is additive to the Bohr effect4
Heterogeneous phenotype of Hereditary Xerocytosis in association with PIEZO1 variants4
Analysis of baseline characteristics, disease burden and long-term follow-up of 167 patients with Paroxysmal Nocturnal Hemoglobinuria at a single center in Brazil4
Co-morbidities and mortality in patients with sickle cell disease in England: A 10-year cohort analysis using hospital episodes statistics (HES) data4
Molecular genetic diagnosis by next-generation sequencing in a cohort of Mexican patients with haemophilia and report of novel variants4